WEST LAFAYETTE, Ind. (AP): A company based at the Purdue Research Park has received a $15 million boost to its work on technology designed to boost the amount of cancerous tissue surgeons can remove. The new funding will go toward additional clinical trials needed to optimize technology developed by OnTarget. It causes cancerous tissues to light up with fluorescent imaging during surgery.